The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 19, 2017

Primary Completion Date

February 28, 2023

Study Completion Date

December 31, 2023

Conditions
Pulmonary Hypertension
Interventions
DEVICE

Occlutech AFR Device

Catheter-guided transeptal placement of an AFR device following balloon atrial septostomy (BAS) -procedure.

Trial Locations (17)

81377

RECRUITING

Klinikum der Universität München, Munich

Unknown

COMPLETED

Elisabeth Krankenhaus, Essen

RECRUITING

Justus-Liebig Universität, Giesen

RECRUITING

Universitätsklinikum Würzburg, Würzburg

RECRUITING

University of Groningen, Groningen

RECRUITING

St. Antonius Ziekenhuis, Nieuwegein

RECRUITING

Gdański Uniwersytet Medyczny, Gdansk

RECRUITING

Uniwersytet Jagielloński Collegium Medicum, Krakow

RECRUITING

Szpital im. Fryderyka Chopina, Otwock

RECRUITING

Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego, Poznan

RECRUITING

Hacettepe Üniversitesi Tıp Fakültesi, Altındağ

RECRUITING

Ankara Dışkapı Yıldırım Beyazıt Hastanesi, Ankara

COMPLETED

Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Istanbul

ACTIVE_NOT_RECRUITING

Ege Üniversitesi Tıp Fakültesi Hastanesi, Izmir

RECRUITING

Sağlık Bilimleri Üniversitesi Tepecik Eğitim ve Araştırma Hastanesi, Izmir

RECRUITING

Kocaeli Üniversitesi Araştırma ve Uygulama Hastanesi, Kocaeli

WITHDRAWN

Sivas Cumhuriyet Üniversitesi Tıp Fakültesi, Sivas

Sponsors
All Listed Sponsors
lead

Occlutech International AB

INDUSTRY